Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04046445
Title Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Amal Therapeutics
Indications

colorectal cancer

Therapies

ATP128 + Ezabenlimab

ATP128

ATP128 + Ezabenlimab + VSV-GP128

Age Groups: senior | adult
Covered Countries USA | BEL


No variant requirements are available.